Related Experiment Video
Updated: Jun 20, 2026

MicroRNA In situ Hybridization for Formalin Fixed Kidney Tissues
Published on: November 30, 2013
Downregulation of ABCD1 in human renal cell carcinoma
Tzyh-Chyuan Hour1, Yi-Zih Kuo, Guang-Yan Liu
1Institute of Biochemistry, Kaohsiung Medical University, Kaohsiung, Taiwan.
Abstract:
Renal cell carcinoma (RCC) is the most common malignant tumor of the kidney. Delayed diagnosis may result in progression and metastasis. Markers for early detection of RCC are lacking. The ATP-binding cassette transporter D1 (ABCD1) is located in the human peroxisome membrane. Its mutation causes X-linked adrenoleukodystrophy (X-ALD), a peroxisomal disorder affecting lipid storage. The role of ABCD1 in human renal tumorigenesis was unclear. In this study, three pairs of RCC tissues were examined by cDNA microarray and data suggested that ABCD1 mRNA is downregulated. Downregulation of ABCD1 expression was confirmed by real-time PCR. ABCD1 expression was also downregulated in four renal cancer cell lines compared to immortalized benign renal tubular cells. ABCD1 mRNA and protein expression levels assessed by immunohistochemistry in the RCC tissues were similar between genders, tumor grades, and tumor stages. Immunohistochemical assays also showed that ABCD1 expression was significantly higher in normal than in cancerous tissues (p<0.001). ABCD1 downregulation may be involved in human renal tumorigenesis.
Insights
Researchers found that ATP-binding cassette transporter D1 (ABCD1) is downregulated in renal cell carcinoma (RCC). This suggests ABCD1 may play a role in kidney cancer development, potentially serving as an early detection marker.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Renal cell carcinoma (RCC) is the most prevalent kidney malignancy.
- Early detection markers for RCC are currently insufficient, leading to potential progression and metastasis.
- The function of ATP-binding cassette transporter D1 (ABCD1) in renal tumorigenesis remains largely uncharacterized.
Purpose of the Study:
- To investigate the role of ABCD1 in the development of human renal cell carcinoma.
- To determine if ABCD1 expression is altered in RCC tissues and cell lines.
Main Methods:
- cDNA microarray analysis of three RCC tissue pairs.
- Real-time PCR to confirm ABCD1 mRNA expression.
- Immunohistochemistry to assess ABCD1 protein levels in tissues and cell lines.
Main Results:
- ABCD1 mRNA expression was found to be downregulated in RCC tissues compared to normal kidney tissues.
- Downregulation of ABCD1 was also observed in renal cancer cell lines.
- Immunohistochemical analysis revealed significantly higher ABCD1 expression in normal renal tissues than in cancerous tissues (p<0.001).
Conclusions:
- The study indicates a significant downregulation of ABCD1 in renal cell carcinoma.
- Altered ABCD1 expression may be implicated in the pathogenesis of human renal tumorigenesis.
- ABCD1 warrants further investigation as a potential biomarker for early RCC detection.
Related Concept Videos
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Inhibition of Cdk Activity
Inhibition of CDK Activity
Abnormal Proliferation
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
